Fineline Cube

Follow:
14486 Articles
Jiangsu Yuyue Partners with Inogen for International Distribution and R&D
CompanyDeals

Jiangsu Yuyue Partners with Inogen for International Distribution and R&D

Guangzhou Innogen's Efsubaglutide Alfa Approved by NMPA for Type 2 Diabetes
CompanyDrug

Guangzhou Innogen’s Efsubaglutide Alfa Approved by NMPA for Type 2 Diabetes

MSD and Eisai's Keytruda/Lenvima Combo Shows Promise in Gastroesophageal Cancer Study
CompanyDrug

MSD and Eisai’s Keytruda/Lenvima Combo Shows Promise in Gastroesophageal Cancer Study

NHSA Targets Low-Volume Drugs in National Reimbursement List
Policy / Regulatory

NHSA Targets Low-Volume Drugs in National Reimbursement List

Novo Nordisk's Amycretin Shows Promising Weight Loss Results in Phase Ib/IIa Study
CompanyDrug

Novo Nordisk’s Amycretin Shows Promising Weight Loss Results in Phase Ib/IIa Study

Jiangsu Vcare PharmaTech Secures RMB200 Million in Series C+ Financing
CompanyDeals

Jiangsu Vcare PharmaTech Secures RMB200 Million in Series C+ Financing

GeneQuantum Secures $13 Billion Deals with Biohaven and AimedBio for ADC Development
CompanyDeals

GeneQuantum Secures $13 Billion Deals with Biohaven and AimedBio for ADC Development

Sinopharm Partners with Biogen for Comprehensive Service Agreement
CompanyDeals

Sinopharm Partners with Biogen for Comprehensive Service Agreement

Boehringer Ingelheim's Nerandomilast Granted Priority Review for IPF in China
CompanyDrug

Boehringer Ingelheim’s Nerandomilast Granted Priority Review for IPF in China

Mirxes Holding Files for Hong Kong IPO with Focus on miRNA Test Kits
CompanyDeals

Mirxes Holding Files for Hong Kong IPO with Focus on miRNA Test Kits

Shenzhen Kangtai Halts COVID-19 Vaccine Development Amid Market Shifts
CompanyDrug

Shenzhen Kangtai Halts COVID-19 Vaccine Development Amid Market Shifts

Huadong Medicine's Ellansé M Filing Accepted by China's NMPA
CompanyMedical Device

Huadong Medicine’s Ellansé M Filing Accepted by China’s NMPA